198 related articles for article (PubMed ID: 21091619)
1. Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment.
Crotser CB; Dickerson SS
J Nurs Scholarsh; 2010 Dec; 42(4):367-78. PubMed ID: 21091619
[TBL] [Abstract][Full Text] [Related]
2. Learning about a twist in the road: perspectives of at-risk relatives learning of potential for cancer.
Crotser CB; Dickerson SS
Oncol Nurs Forum; 2010 Nov; 37(6):723-33. PubMed ID: 21059584
[TBL] [Abstract][Full Text] [Related]
3. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
4. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
Chopra I; Kelly KM
J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
[TBL] [Abstract][Full Text] [Related]
5. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
Geller G; Doksum T; Bernhardt BA; Metz SA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
[TBL] [Abstract][Full Text] [Related]
6. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
[TBL] [Abstract][Full Text] [Related]
7. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
[TBL] [Abstract][Full Text] [Related]
8. Communicating BRCA1/2 genetic test results within the family: a qualitative analysis.
Dancyger C; Wiseman M; Jacobs C; Smith JA; Wallace M; Michie S
Psychol Health; 2011 Aug; 26(8):1018-35. PubMed ID: 21797732
[TBL] [Abstract][Full Text] [Related]
9. Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy.
Hanoch Y; Miron-Shatz T; Rolison JJ; Ozanne E
Psychooncology; 2014 Oct; 23(10):1142-8. PubMed ID: 24733657
[TBL] [Abstract][Full Text] [Related]
10. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.
Hallowell N; Ardern-Jones A; Eeles R; Foster C; Lucassen A; Moynihan C; Watson M
Clin Genet; 2005 Jun; 67(6):492-502. PubMed ID: 15857416
[TBL] [Abstract][Full Text] [Related]
11. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
12. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
[TBL] [Abstract][Full Text] [Related]
13. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
[TBL] [Abstract][Full Text] [Related]
14. Living with gynecologic cancer: experience of women and their partners.
Akyüz A; Güvenç G; Ustünsöz A; Kaya T
J Nurs Scholarsh; 2008; 40(3):241-7. PubMed ID: 18840207
[TBL] [Abstract][Full Text] [Related]
15. Intention to communicate BRCA1/BRCA2 genetic test results to the family.
Barsevick AM; Montgomery SV; Ruth K; Ross EA; Egleston BL; Bingler R; Malick J; Miller SM; Cescon TP; Daly MB
J Fam Psychol; 2008 Apr; 22(2):303-12. PubMed ID: 18410217
[TBL] [Abstract][Full Text] [Related]
16. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
[TBL] [Abstract][Full Text] [Related]
17. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
Brunsvold AN; Wung SF; Merkle CJ
J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
[TBL] [Abstract][Full Text] [Related]
19. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
Dorval M; Gauthier G; Maunsell E; Dugas MJ; Rouleau I; Chiquette J; Plante M; Laframboise R; Gaudet M; Bridge PJ; Simard J
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2862-7. PubMed ID: 16365001
[TBL] [Abstract][Full Text] [Related]
20. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.
Smith KR; West JA; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):385-92. PubMed ID: 10207644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
